Clinical Trial Update: Adjuvant Therapy(3 vs. 6 Months) With the FOLFOX 4 or XELOX for Stage II or Stage III Colon Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating 3 versus 6 months of adjuvant FOLFOX4 or XELOX for stage II/III colon cancer. The current status of the trial is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Capecitabine (capecitabine)
• Leucovorin (folinic acid) (folinic acid)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Hellenic Oncology Research Group | Conditions: CRC | Phase 3 | Status: UNKNOWN